$ACHV
ACHIEVE LIFE SCIENCES, INC.

2015 Q1 Form 10-K Financial Statement

#000156459015002010 Filed on March 26, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1 2014
Revenue $1.374M $11.73M $27.12M
YoY Change -88.29% 130.91% -9.25%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.700M $2.760M $10.63M
YoY Change -2.17% 10.4% 7.48%
% of Gross Profit
Research & Development $3.673M $16.90M $46.22M
YoY Change -78.27% 55.72% -16.44%
% of Gross Profit
Depreciation & Amortization $46.00K $55.00K $223.0K
YoY Change -16.36% 25.0% -1.76%
% of Gross Profit
Operating Expenses $6.371M $16.90M $46.22M
YoY Change -62.31% 55.72% -29.11%
Operating Profit
YoY Change
Interest Expense $50.00K $10.00K $40.00K
YoY Change 400.0% -80.0% -73.33%
% of Operating Profit
Other Income/Expense, Net $480.0K -$707.0K $3.226M
YoY Change -167.89% -144.69% -7.25%
Pretax Income -$4.520M -$8.640M -$26.24M
YoY Change -47.69% 28.96% -17.61%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$4.517M -$8.636M -$26.24M
YoY Change -47.7% 28.95% -17.61%
Net Earnings / Revenue -328.75% -73.62% -96.77%
Basic Earnings Per Share
Diluted Earnings Per Share -$452.0M -$864.0M -$2.624B
COMMON SHARES
Basic Shares Outstanding 22.68M 14.72M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q1 2014
SHORT-TERM ASSETS
Cash & Short-Term Investments $40.40M $37.60M $47.06M
YoY Change 7.45% -41.8% 19.99%
Cash & Equivalents $25.28M $28.63M $11.42M
Short-Term Investments $15.10M $8.900M $19.16M
Other Short-Term Assets $499.0K $1.800M $2.920M
YoY Change -72.28% -47.06% -49.39%
Inventory
Prepaid Expenses
Receivables $1.559M $8.610M $5.680M
Other Receivables $0.00 $200.0K $110.0K
Total Short-Term Assets $45.51M $48.15M $55.76M
YoY Change -5.49% -34.49% 3.51%
LONG-TERM ASSETS
Property, Plant & Equipment $416.0K $349.0K $260.0K
YoY Change 19.2% -12.75% -35.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $272.0K $1.075M $270.0K
YoY Change -74.7% -28.33% -81.12%
Total Long-Term Assets $878.0K $1.675M $530.0K
YoY Change -47.58% -11.84% -70.88%
TOTAL ASSETS
Total Short-Term Assets $45.51M $48.15M $55.76M
Total Long-Term Assets $878.0K $1.675M $530.0K
Total Assets $46.38M $49.82M $56.29M
YoY Change -6.9% -33.92% 1.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $988.0K $923.0K $70.00K
YoY Change 7.04% -88.32% -50.0%
Accrued Expenses $11.40M $13.04M $15.66M
YoY Change -12.58% 16.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $1.100M $240.0K
YoY Change -90.91% 0.0% -77.98%
Total Short-Term Liabilities $16.24M $16.90M $22.22M
YoY Change -3.92% 53.64% 48.83%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $3.300M $10.00K
YoY Change -96.97% -19.51% -99.72%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $100.0K $3.300M $10.00K
YoY Change -96.97% -19.51% -99.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.24M $16.90M $22.22M
Total Long-Term Liabilities $100.0K $3.300M $10.00K
Total Liabilities $16.37M $20.22M $22.23M
YoY Change -19.07% 33.91% 20.29%
SHAREHOLDERS EQUITY
Retained Earnings -$164.5M -$142.3M
YoY Change 15.6%
Common Stock $191.9M $169.3M
YoY Change 13.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $30.02M $29.60M $34.06M
YoY Change
Total Liabilities & Shareholders Equity $46.38M $49.82M $56.29M
YoY Change -6.9% -33.92% 1.08%

Cashflow Statement

Concept 2015 Q1 2014 Q1 2014
OPERATING ACTIVITIES
Net Income -$4.517M -$8.636M -$26.24M
YoY Change -47.7% 28.95% -17.61%
Depreciation, Depletion And Amortization $46.00K $55.00K $223.0K
YoY Change -16.36% 25.0% -1.76%
Cash From Operating Activities -$6.440M -$1.690M -$17.31M
YoY Change 281.07% -84.19% -51.82%
INVESTING ACTIVITIES
Capital Expenditures $205.0K $7.000K $82.00K
YoY Change 2828.57% -93.64% -67.59%
Acquisitions
YoY Change
Other Investing Activities $4.080M $15.71M $5.450M
YoY Change -74.03% 38.41% -83.32%
Cash From Investing Activities $3.880M $15.70M $5.370M
YoY Change -75.29% 39.68% -83.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $22.37M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -50.00K 30.00K 25.25M
YoY Change -266.67% 200.0% 252400.0%
NET CHANGE
Cash From Operating Activities -6.440M -1.690M -17.31M
Cash From Investing Activities 3.880M 15.70M 5.370M
Cash From Financing Activities -50.00K 30.00K 25.25M
Net Change In Cash -2.610M 14.04M 13.31M
YoY Change -118.59% 2407.14% -481.27%
FREE CASH FLOW
Cash From Operating Activities -$6.440M -$1.690M -$17.31M
Capital Expenditures $205.0K $7.000K $82.00K
Free Cash Flow -$6.645M -$1.697M -$17.39M
YoY Change 291.57% -84.29% -51.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22679086
CY2014Q2 dei Entity Public Float
EntityPublicFloat
48992133
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27897000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14593000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
251000
CY2014Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
3002000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22218000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
14000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2837000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26261000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
34059000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2622000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
22000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56291000
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
35000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-159958000
CY2014 us-gaap Costs And Expenses
CostsAndExpenses
56582000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
191373000
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
65209000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
863000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
236000
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39948000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
72000
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1333000
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-21098000
CY2012 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4459000
CY2013 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2012 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
20095000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8657000
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
499000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
53867000
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
292000
CY2013Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
1092000
CY2012 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
138000
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31843000
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14683389
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9892000
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55317000
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10625000
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7791000
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
150000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5676000
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
CY2013 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
273000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
257000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
397000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
55761000
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6000
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
13522723
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.17
CY2014Q4 us-gaap Liabilities
Liabilities
22232000
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Liabilities
Liabilities
18478000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
3544000
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
46082000
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4889000
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3226000
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3741000
CY2012 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21097000
CY2013 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3208000
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3478000
CY2013Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
218000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-133689000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5770000
CY2013Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
314000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1111000
CY2014Q4 us-gaap Assets
Assets
56291000
CY2013Q4 us-gaap Assets
Assets
55689000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
139000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
500000
CY2014Q4 ogxi Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
13462000
CY2013Q4 ogxi Accrued Liabilities Clinical Current
AccruedLiabilitiesClinicalCurrent
11284000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1705000
CY2013Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
214000
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
19160000
CY2013Q4 us-gaap Short Term Investments
ShortTermInvestments
24629000
CY2014Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
113000
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
14934000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
15000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
168242000
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2643000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
37211000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55689000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22630652
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22621426
CY2014 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
27116000
CY2013 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
29882000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46224000
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2165000
CY2014Q4 ogxi Lease Termination Liability Current
LeaseTerminationLiabilityCurrent
3250000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14707886
CY2014 ogxi Restructuring Costs Net
RestructuringCostsNet
267000
CY2012 ogxi Restructuring Costs Net
RestructuringCostsNet
1657000
CY2014 ogxi Warrant Issuance Costs
WarrantIssuanceCosts
531000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-21000
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.45
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18098799
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
30890000
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2175000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
66207000
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3860000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000
CY2014 ogxi Stock Issued During Period Value Performance Restricted Stock Unit Settlements Withheld And Retired To Treasury
StockIssuedDuringPeriodValuePerformanceRestrictedStockUnitSettlementsWithheldAndRetiredToTreasury
29000
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2860000
CY2014 us-gaap Depreciation
Depreciation
223000
CY2013 us-gaap Depreciation
Depreciation
227000
CY2012 us-gaap Depreciation
Depreciation
100000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
3860000
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
2834000
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
2175000
CY2014 us-gaap Restructuring Costs
RestructuringCosts
-3517000
CY2012 us-gaap Restructuring Costs
RestructuringCosts
-1657000
CY2012 us-gaap Nonmonetary Transaction Gain Loss Recognized On Transfer
NonmonetaryTransactionGainLossRecognizedOnTransfer
151000
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
291000
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
462000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2039000
CY2014Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
2000000
CY2013Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2014Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14707886
CY2014 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
441000
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1967000
CY2013Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
951000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
76403000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
72115000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
7464000
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6857000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3163000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2578000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
110000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
70000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
91986000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
84138000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
91986000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84138000
CY2013Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
766828
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
172650
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
12309
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4541
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
805281
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
239282
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3061
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
30536
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
13.87
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.39
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
382097
CY2014 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-105000
CY2013 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-109000
CY2012 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-36000
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-10442000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18075000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28517000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2981000
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7943000
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
265000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3944000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1974000
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3037000
CY2014 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-67000
CY2013 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1190000
CY2012 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-175000
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
363000
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
41000
CY2012 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
269000
CY2014 ogxi Increase Decrease In Accrued Liabilities Clinical
IncreaseDecreaseInAccruedLiabilitiesClinical
2178000
CY2013 ogxi Increase Decrease In Accrued Liabilities Clinical
IncreaseDecreaseInAccruedLiabilitiesClinical
7563000
CY2012 ogxi Increase Decrease In Accrued Liabilities Clinical
IncreaseDecreaseInAccruedLiabilitiesClinical
3150000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-372000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
164000
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
589000
CY2014 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
CY2012 us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
-63000
CY2014 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-785000
CY2013 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-680000
CY2012 us-gaap Increase Decrease In Restructuring Reserve
IncreaseDecreaseInRestructuringReserve
-795000
CY2014 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
84000
CY2013 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
21000
CY2012 ogxi Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
-33000
CY2014 ogxi Increase Decrease In Lease Termination Fee
IncreaseDecreaseInLeaseTerminationFee
3250000
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-18271000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17308000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-35927000
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-43493000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
30000
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10000
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
462000
CY2014 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
29000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
22372000
CY2012 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53777000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25247000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10000
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
54239000
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
19446000
CY2013 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
31696000
CY2012 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
110443000
CY2013 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1000000
CY2012 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
7365000
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
24894000
CY2013 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
63375000
CY2012 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
82181000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
253000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5366000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
32426000
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-21188000
CY2014 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
9000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
13304000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3482000
CY2012 ogxi Income Tax Reconciliation Reduction In Benefit Of Other Tax Attributes
IncomeTaxReconciliationReductionInBenefitOfOtherTaxAttributes
551000
CY2012 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-1212000
CY2013 ogxi Property And Equipment Acquired Under Lease Obligation
PropertyAndEquipmentAcquiredUnderLeaseObligation
24000
CY2014 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-9000
CY2013 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-744000
CY2014 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1445000
CY2013 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
2003000
CY2012 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1672000
CY2013 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
-10000
CY2012 ogxi Income Tax Reconciliation Change In Benefit Of Operating Losses
IncomeTaxReconciliationChangeInBenefitOfOperatingLosses
15000
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and notes thereto. Actual results could differ from these estimates. Estimates and assumptions principally relate to estimates of the fair value of our warrant liability and excess lease facility liability, the initial fair value and forfeiture rates of stock options issued to employees and consultants, the estimated compensation cost on performance restricted stock unit awards and clinical trial and manufacturing accruals. </p></div>
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
19179000
CY2014Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2014Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000
CY2014Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
19160000
CY2013Q4 us-gaap Cash
Cash
10575000
CY2013Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
24627000
CY2013Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2013Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-3741000
CY2013Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
24629000
CY2014 ogxi Maximum Maturity Period Of Cash And Cash Equivalents
MaximumMaturityPeriodOfCashAndCashEquivalents
P90D
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1294000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1211000
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
47308000
CY2013Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
39536000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1037000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
814000
CY2014 ogxi Period Of Not Utilizing Prepaid Amounts Related To Clinical Trials
PeriodOfNotUtilizingPrepaidAmountsRelatedToClinicalTrials
P12M
CY2012 us-gaap Nonmonetary Transaction Amount Of Barter Transaction
NonmonetaryTransactionAmountOfBarterTransaction
0
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2011 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2013 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2012 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2014 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2012 ogxi Maximum Maturity Period Of Short Term Investments
MaximumMaturityPeriodOfShortTermInvestments
P1Y
CY2014 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2014 ogxi Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P174D
CY2013 ogxi Average Period To Maturity For Portfolio Of Cash And Marketable Securities
AveragePeriodToMaturityForPortfolioOfCashAndMarketableSecurities
P50D
CY2014Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3002000
CY2013Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
214000
CY2014 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
6529000
CY2014Q4 us-gaap Cash
Cash
16481000
CY2011 ogxi Future Income Tax Rate Assumed For Deferred Tax Calculations
FutureIncomeTaxRateAssumedForDeferredTaxCalculations
0.34
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-8922000
CY2013 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-10829000
CY2012 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7152000
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-452000
CY2013 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-738000
CY2014Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
47100000
CY2014 ogxi Maturity Period Of Highly Liquid Investments To Be Considered As Cash Equivalent
MaturityPeriodOfHighlyLiquidInvestmentsToBeConsideredAsCashEquivalent
P3M
CY2014 ogxi Description Of Maturity Period Of Financial Instruments To Be Considered As Short Term Investment
DescriptionOfMaturityPeriodOfFinancialInstrumentsToBeConsideredAsShortTermInvestment
Greater than three months and less than one year
CY2014 ogxi Amount To Be Spent In Direct And Indirect Development Costs Under Agreement
AmountToBeSpentInDirectAndIndirectDevelopmentCostsUnderAgreement
30000000
CY2012 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
30000000
CY2009 us-gaap Licenses Revenue
LicensesRevenue
22000000
CY2014 ogxi Collaboration Maximum Additional Payment Received Achievement Of Developmental And Commercial Milestones
CollaborationMaximumAdditionalPaymentReceivedAchievementOfDevelopmentalAndCommercialMilestones
370000000
CY2014 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
357000
CY2013 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
347000
CY2012 us-gaap Income Tax Reconciliation Tax Credits Investment
IncomeTaxReconciliationTaxCreditsInvestment
485000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7854000
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
10538000
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6324000
CY2013 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
127000
CY2012 ogxi Income Tax Reconciliation Book To Tax Return Adjustments
IncomeTaxReconciliationBookToTaxReturnAdjustments
287000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
151112000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
150200000
CY2014Q4 ogxi Non Capital Loss Carryforwards Amount
NonCapitalLossCarryforwardsAmount
96307000
CY2014 ogxi Unclaimed Tax Deductions Related To Scientific Research And Experimental Development Expenditures
UnclaimedTaxDeductionsRelatedToScientificResearchAndExperimentalDevelopmentExpenditures
14800000
CY2014 ogxi Tax Credit Carryforward Expiration Year Range Start
TaxCreditCarryforwardExpirationYearRangeStart
2015
CY2014 ogxi Tax Credit Carryforward Expiration Year Range End
TaxCreditCarryforwardExpirationYearRangeEnd
2034
CY2014Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
4871000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
-25000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Restructuring Charges
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsRestructuringCharges
1567000
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
4.11
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2007000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
32000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
32000
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
8000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2010Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3174602
CY2014 us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
Each unit consisting of one share of our common stock and one-half (1/2) of one warrant
CY2010Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
50000000
CY2010Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
20
CY2010Q4 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
46700000
CY2010Q4 ogxi Additional Common Shares Due To Allocated By Proceeds From Warrant Issued
AdditionalCommonSharesDueToAllocatedByProceedsFromWarrantIssued
32300000
CY2010Q4 ogxi Additional Warrant Liability Due To Allocated By Proceeds From Warrant Issued
AdditionalWarrantLiabilityDueToAllocatedByProceedsFromWarrantIssued
15400000
CY2010Q4 ogxi Warrant Issuance Expenses
WarrantIssuanceExpenses
1000000
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4165000
CY2012Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
12.00
CY2014 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
57500000
CY2012Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
53800000
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
100000
CY2014Q3 ogxi Common Stock Sales Agreement Net Amount
CommonStockSalesAgreementNetAmount
22000000
CY2014Q3 ogxi Net Proceeds Received From Offering After Deducting Underwriting Discounts And Offering Expenses
NetProceedsReceivedFromOfferingAfterDeductingUnderwritingDiscountsAndOfferingExpenses
22400000
CY2014Q3 us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
24000000
CY2014Q3 ogxi Warrant Issuance Costs
WarrantIssuanceCosts
1600000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3475
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
117347
CY2014 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
203148
CY2013 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
47495
CY2012 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0183
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0125
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0096
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M18D
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.82
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.86
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.95
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.52
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.07
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
9.86
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1007491
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
12169
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1283419
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.82
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.97
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.10
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.94
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
15.26
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.34
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.32
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.97
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
18.93
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.00
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.14
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.55
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
1283419
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
10.55
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P6Y3M18D
CY2014Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
851612
CY2014Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
11.12
CY2014 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P4Y11M12D
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
2700000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1900000
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1800000
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1600000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
51100
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
34000
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4680
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
0
CY2013 ogxi Number Of Warrants Exercised
NumberOfWarrantsExercised
0
CY2014 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
One-for-eighteen reverse stock split
CY2014 ogxi Shareholder Rights Plan To Acquire Additional Shares Of Common Stock
ShareholderRightsPlanToAcquireAdditionalSharesOfCommonStock
0.15
CY2014 ogxi Number Of Rights Associated With Per Share Of Common Stock
NumberOfRightsAssociatedWithPerShareOfCommonStock
18
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2600000
CY2014 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2013 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2012 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
0
CY2014Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2014 ogxi Expiration Of Operating Lease Agreement
ExpirationOfOperatingLeaseAgreement
2015-09
CY2014 ogxi Expiration Of Non Cancellable Operating Lease Agreement
ExpirationOfNonCancellableOperatingLeaseAgreement
2017
CY2014Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
300000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2800000
CY2012 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2700000
CY2014Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2014 ogxi Indemnification Expense
IndemnificationExpense
0
CY2014Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
11731000
CY2014Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
4929000
CY2014Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
4803000
CY2014Q4 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
5653000
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16903000
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9883000
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9586000
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9852000
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2757000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2676000
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2459000
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2733000
CY2014Q4 us-gaap Restructuring Costs
RestructuringCosts
-267000
CY2014Q1 us-gaap Costs And Expenses
CostsAndExpenses
19660000
CY2014Q2 us-gaap Costs And Expenses
CostsAndExpenses
12559000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
12045000
CY2014Q4 us-gaap Costs And Expenses
CostsAndExpenses
12318000
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-707000
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
615000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2335000
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
983000
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-8636000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-7015000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-4907000
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-5682000
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.59
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.47
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.23
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2013Q1 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
5076000
CY2013Q2 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
6340000
CY2013Q3 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
9862000
CY2013Q4 ogxi Revenues From Collaborative Agreements
RevenuesFromCollaborativeAgreements
8604000
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10855000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13263000
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18004000
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13195000
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2500000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2473000
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2473000
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2446000
CY2013Q1 us-gaap Costs And Expenses
CostsAndExpenses
13355000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
15736000
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
20477000
CY2013Q4 us-gaap Costs And Expenses
CostsAndExpenses
15641000
CY2013Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1582000
CY2013Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
976000
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
561000
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
359000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-6697000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-8420000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-10054000
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-6678000
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.46
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.45

Files In Submission

Name View Source Status
0001564590-15-002010-index-headers.html Edgar Link pending
0001564590-15-002010-index.html Edgar Link pending
0001564590-15-002010.txt Edgar Link pending
0001564590-15-002010-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g201503260127535811084.jpg Edgar Link pending
g20150326012813495824.jpg Edgar Link pending
g20150326012813541825.jpg Edgar Link pending
g20150326012813588826.jpg Edgar Link pending
g20150326012813948827.jpg Edgar Link pending
g20150326012814010828.jpg Edgar Link pending
g20150326012814057829.jpg Edgar Link pending
g20150326012814120830.jpg Edgar Link pending
g20150326012814182831.jpg Edgar Link pending
g20150326012814229832.jpg Edgar Link pending
g20150326012814276833.jpg Edgar Link pending
g20150326012815104834.jpg Edgar Link pending
g20150326012816698835.jpg Edgar Link pending
g20150326012826339836.jpg Edgar Link pending
g20150326012830245837.jpg Edgar Link pending
ogxi-10k_20141231.htm Edgar Link pending
ogxi-20141231.xml Edgar Link completed
ogxi-20141231.xsd Edgar Link pending
ogxi-20141231_cal.xml Edgar Link unprocessable
ogxi-20141231_def.xml Edgar Link unprocessable
ogxi-20141231_lab.xml Edgar Link unprocessable
ogxi-20141231_pre.xml Edgar Link unprocessable
ogxi-ex1041_201412312130.htm Edgar Link pending
ogxi-ex211_20141231206.htm Edgar Link pending
ogxi-ex231_20141231205.htm Edgar Link pending
ogxi-ex311_20141231204.htm Edgar Link pending
ogxi-ex312_201412312131.htm Edgar Link pending
ogxi-ex321_20141231203.htm Edgar Link pending
ogxi-ex322_201412312132.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending